JWH-018 binds to each the CB1 and CB2 receptors. The effects of JWH-018 are mainly attributable towards the binding and activation of CB1 receptors. In exercise, the compound suppresses the release of neurotransmitters within the central anxious procedure, which explains the large number of results.